Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) EBT Margin (2023 - 2025)

Historic EBT Margin for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to 0.78%.

  • BioScience Health Innovations' EBT Margin fell 105900.0% to 0.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.74%, marking a year-over-year increase of 162300.0%. This contributed to the annual value of 4.72% for FY2024, which is 468000.0% up from last year.
  • Latest data reveals that BioScience Health Innovations reported EBT Margin of 0.78% as of Q3 2025, which was down 105900.0% from 26.04% recorded in Q2 2025.
  • In the past 5 years, BioScience Health Innovations' EBT Margin registered a high of 34.78% during Q1 2025, and its lowest value of 218.68% during Q1 2023.
  • In the last 3 years, BioScience Health Innovations' EBT Margin had a median value of 0.78% in 2025 and averaged 28.38%.
  • As far as peak fluctuations go, BioScience Health Innovations' EBT Margin soared by 1994600bps in 2024, and later tumbled by -105900bps in 2025.
  • Quarter analysis of 3 years shows BioScience Health Innovations' EBT Margin stood at 12.64% in 2023, then skyrocketed by 113bps to 1.63% in 2024, then crashed by -148bps to 0.78% in 2025.
  • Its EBT Margin was 0.78% in Q3 2025, compared to 26.04% in Q2 2025 and 34.78% in Q1 2025.